United States

People: Amphastar Pharmaceuticals Inc (AMPH.OQ)

AMPH.OQ on NASDAQ Stock Exchange Global Select Market

18 Apr 2019
Change (% chg)

$0.24 (+1.20%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Zhang, Jack 

Dr. Jack Yongfeng Zhang, Ph.D., is Chief Executive Officer, Chief Scientific Officer, Director of the Company. Dr. Zhang co-founded our company in 1996 and has served as our Chief Executive Officer and a member of our board of directors since our inception and as our President from 1996 until June 2013. Dr. Zhang has also served as our Chief Scientific Officer since 2005. Dr. Zhang co-founded APCL, a full service chemical analytical laboratory, in May 1989, where he held the position of President until October 2002. Dr. Zhang is named as the inventor on several U.S. and foreign patents. He received a Ph.D. in chemistry from the State University of New York at Stony Brook and was a Post Doctoral Research Associate at the California Institute of Technology. We believe Dr. Zhang’s experience in the pharmaceutical industry and as one of our founders qualifies him to serve on our board of directors.

Basic Compensation

Total Annual Compensation, USD 1,548,450
Restricted Stock Awards, USD 2,090,000
Long-Term Incentive Plans, USD --
All Other, USD 2,117,080
Fiscal Year Total, USD 5,755,530

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Mary Luo


Jason Shandell


Jack Zhang


William Peters


Rong Zhou


Michael Zasloff

As Of  30 Dec 2017